α-Synuclein phos Ser129 (EP1536Y)

ANTIBODY monoclonal EP1536Y manufacturer Cat# ab51253 immunogen = a phosphor specific peptide corresp. to residues surrounding Serine 129 of human alpha Synuclein liquid, supernatant, BSA, saline, glycerol, Tris glycine, azide detects alpha synuclein phosphorylate

α-Synuclein phos Ser87

ANTIBODY polyclonal laboratory S87-P<br />(<a href="http://nmnf.epfl.ch/page9209.html" target="_new">Hilal Lashel</a>, The Swiss Federal Institute of Technology-Lausanne)<br />Reference: <br /><a href="/pap

Hans Wouters

Netherlands

PAPER Lo B, Parham L

Resolving ethical issues in stem cell clinical trials: the example of Parkinson disease.

J Law Med Ethics. 2010 Summer;38(2):257-66. PubMed: 20579249

PAPER Wichterle H, Przedborski S

What can pluripotent stem cells teach us about neurodegenerative diseases?

Nat Neurosci. 2010 Jul;13(7):800-4. PubMed: 20581816

PAPER Sendtner M

Therapy development in spinal muscular atrophy.

Nat Neurosci. 2010 Jul;13(7):795-9. PubMed: 20581815

St. Louis: ApoE Receptors—Hold Sway Over Synaptic Function

CONFERENCE COVERAGE 2010-06-30 Conference Coverage The apolipoprotein E gene is the strongest genetic risk factor for late-onset Alzheimer disease. One ApoE4 allele almost quadruples a person’s chances of getting the disease, while having two drives up the risk by 12- to 15-fold. Not s

PAPER Wang J, Ono K, Dickstein DL, Arrieta-Cruz I, Zhao W, Qian X, Lamparello A, Subnani R, Ferruzzi M, Pavlides C, Ho L, Hof PR, Teplow DB, Pasinetti GM

Carvedilol as a potential novel agent for the treatment of Alzheimer's disease.

Neurobiol Aging. 2011 Dec;32(12):2321.e1-12. PubMed: 20579773

PAPER Clarke B, Cutler L, Demont E, Dingwall C, Dunsdon R, Hawkins J, Howes C, Hussain I, Maile G, Matico R, Mosley J, Naylor A, O'Brien A, Redshaw S, Rowland P, Soleil V, Smith KJ, Sweitzer S, Theobald P, Vesey D, Walter DS, Wayne G